Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics
Heat shock protein 90 (Hsp90) is a promising cancer drug target as a molecular chaperone critical for stabilization and activation of several of the oncoproteins that drive cancer progression. Its actions depend upon its essential ATPase, an activity fortuitously inhibited with a very high degree of...
Main Authors: | Peter W. Piper, Stefan H. Millson |
---|---|
Format: | Article |
Language: | English |
Published: |
The Royal Society
2012-01-01
|
Series: | Open Biology |
Subjects: | |
Online Access: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.120138 |
Similar Items
-
Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators
by: Natalia Skrzypczak, et al.
Published: (2021-01-01) -
Zearalenone and ß-Zearalenol But Not Their Glucosides Inhibit Heat Shock Protein 90 ATPase Activity
by: Juan Antonio Torres Acosta, et al.
Published: (2019-10-01) -
Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in Leishmania donovani
by: Eugenia Bifeld, et al.
Published: (2018-11-01) -
Effect of benzoquinones ansamycins 17AAG onmalignant biological behaviors of gastric cancer cell lines
by: Jian-Xin Fu, et al.
Published: (2016-07-01) -
Life Cycle Stage-Specific Accessibility of <named-content content-type="genus-species">Leishmania donovani</named-content> Chromatin at Transcription Start Regions
by: Janne Grünebast, et al.
Published: (2021-08-01)